Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)

Hong Kong · Delayed Price · Currency is HKD

2.390

+0.010 (0.42%)

Oct 23, 2026, 2:56 PM HKT

Market Cap	584.84M -62.9%
Revenue (ttm)	97.95M -0.4%
Net Income	-33.98M
EPS	-0.14
Shares Out	244.71M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	85,600
Open	2.400
Previous Close	2.380
Day's Range	2.350 - 2.435
52-Week Range	2.350 - 7.000
Beta	-0.84
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About HKG:6922

Cryofocus Medtech (Shanghai) Co., Ltd., a medical device company, engages in the research, development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products in the People’s Republic of China. The company develops products in the areas of vascular interventional therapy for the treatment of atrial fibrillation, hypertension, and other cardiovascular diseases; and natural orifice transluminal endoscopic surgery for the treatment of urinary, respiratory, and digestive diseases. I... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2013

Employees 172

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 6922

Full Company Profile

Financial Performance

In 2025, HKG:6922's revenue was 95.27 million, an increase of 77.97% compared to the previous year's 53.53 million. Losses were -38.17 million, -63.43% less than in 2024.

Financial numbers in CNY Financial Statements